Renalogic Marks a Remarkable Year of Growth with Record Savings for Clients

Renalogic, a leader in the market for managing costs of chronic kidney disease and dialysis for self-funded health plans, has announced a significant year of growth in 2023. The company welcomed almost 100 new clients, representing over 170,000 lives, marking the highest growth in its history. These new clients include a variety of self-funded plans from numerous sectors, such as Taft-Hartley plans, municipal plans, tribal nations, and employers covering multiple industries.

Through these expanded relationships, Renalogic ended the year supporting the financial and clinical health of over 715,000 members across the United States. The company's cost-saving solutions have saved over 60 million dollars for its clients. Additionally, Renalogic has been recertified by the Validation Institute as a significant cost-savings generator for self-funded plans.

In addition to its financial achievements, Renalogic has provided significant clinical support to its members, effectively preventing progression to dialysis and significantly reducing emergency room visits and hospital admissions for enrolled members. The company has also introduced ImpactClarify, a new solution for managing complex claims, expanding its expertise beyond kidney health.

"2023 has been a great year for our clients, members, partners, and employees," said Kevin Weinstein, CEO of Renalogic, highlighting the positive impact of the company on members' lives and the savings realized for clients.